Sorrento Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Sorrento Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2022.
  • Sorrento Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $417M, a 59.5% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $417M +$155M +59.5% Dec 31, 2022 10-K 2023-03-16
Q4 2021 $261M +$57.7M +28.4% Dec 31, 2021 10-K 2023-03-16
Q4 2020 $204M +$55.4M +37.4% Dec 31, 2020 10-K 2022-03-11
Q4 2019 $148M +$73.2M +97.6% Dec 31, 2019 10-K 2021-02-19
Q4 2018 $75M +$31.6M +72.7% Dec 31, 2018 10-K 2020-03-03
Q4 2017 $43.4M -$37.6M -46.4% Dec 31, 2017 8-K 2019-06-17
Q4 2016 $81M +$41.4M +105% Dec 31, 2016 10-K 2018-03-16
Q4 2015 $39.6M +$14.3M +56.2% Dec 31, 2015 10-K/A 2017-03-27
Q4 2014 $25.4M +$13.1M +106% Dec 31, 2014 10-K 2016-03-15
Q4 2013 $12.3M +$7.25M +144% Dec 31, 2013 10-K 2015-03-16
Q4 2012 $5.05M +$2.61M +108% Dec 31, 2012 10-K 2014-04-01
Q4 2011 $2.43M Dec 31, 2011 10-K/A 2013-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.